ln-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy

Primary angioplasty is considered the best reperfusion therapy in the treatment of ST-segment elevation myocardial infarction (STEMI). However, thrombolysis is the reperfusion method most commonly used, due to its wide availability, reduced costs and ease of administration. To compare in-hospital mo...

Full description

Saved in:
Bibliographic Details
Published in:Revista medíca de Chile 2008-02, Vol.136 (2), p.143-150
Main Authors: Prieto, Juan Carlos, Sanhueza, Consuelo, Martínez, Nicolás, Nazzal, Carolina, Corbalán, Ramón, Cavada, Gabriel, Lanas, Fernando, Bartolucci, Jorge, Campos, Pabla
Format: Article
Language:Spanish
Subjects:
Angioplasty, Balloon, Coronary - mortality
Female
Fibrinolytic Agents - therapeutic use
Hospital Mortality
Humans
Logistic Models
Male
Middle Aged
Myocardial Infarction - mortality
Myocardial Infarction - therapy
Risk Factors
Sex Factors
Streptokinase - therapeutic use
Thrombolytic Therapy - mortality
Tissue Plasminogen Activator - therapeutic use
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Primary angioplasty is considered the best reperfusion therapy in the treatment of ST-segment elevation myocardial infarction (STEMI). However, thrombolysis is the reperfusion method most commonly used, due to its wide availability, reduced costs and ease of administration. To compare in-hospital mortality in STEMI patients according to reperfusion therapy. Patients admitted to Chilean hospitals participating in the GEMI network, from 2001 to 2005, with STEMI were included. They were divided in three groups: a) treated with thrombolytics, b) treated with primary angioplasty, c) without reperfusion procedure. In-hospital mortality according to gender, was analyzed in each group, using a logistic regression method, to assess risk factors associated with mortality. We included 3,255 patients. Global mortality was 9.9% (7.5% in men and 16.7% in women, p
ISSN:0034-9887